Evidence map›Paper›PMID 40378217›Full record

ArticleScience advances2025

Upgraded circular single-stranded DNA regulators for multiple-input multiple-output gene circuits in mammalian cells.

Linlin Tang, Jinghao Wang, Kaiqi Xu, Zhen Li, Jie Song

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Linlin TangHangzhou Institute of Medicine, Chinese Academy of Sciences, Zhejiang, Hangzhou, 310022, China.ORCID 0000-0002-6337-4363
Jinghao WangHangzhou Institute of Medicine, Chinese Academy of Sciences, Zhejiang, Hangzhou, 310022, China.
Kaiqi XuHangzhou Institute of Medicine, Chinese Academy of Sciences, Zhejiang, Hangzhou, 310022, China.
Zhen LiInstitute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Jie SongHangzhou Institute of Medicine, Chinese Academy of Sciences, Zhejiang, Hangzhou, 310022, China.ORCID 0000-0002-4711-6014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic gene networks hold promise for genetic diagnostics and gene therapy but face limitations due to insufficient molecular tools. Gene-encoded circular single-stranded DNA (Css DNA) has been developed as a switchable vector to enrich regulatory components beyond protein/RNA-based systems in mammalian cells. However, the previous Css DNA regulator suffered from constrained regulatory sequence flexibility, disability of multiple-input multiple-output (MIMO) signals, and lack of endogenous orthogonal regulation. Here, we address these challenges by engineering a "bridge" design into the Css DNA regulator. These bridges function as sequence-programmable switches to control gene expression, responding to endogenous molecular signals (such as ATP, APE1, and RNase H) and enabling trans-regulation within or between Css DNAs. We exploit the orthogonality of Css DNA regulator to construct the three-input three-output genetic circuits. The upgraded Css DNA-based regulatory strategy represents a versatile and powerful platform for gene regulation and provides a promising avenue for the development of synthetic gene networks.

Indexed as

DNA, CircularDNA, Single-StrandedGene Expression RegulationGene Regulatory NetworksDNA-(Apurinic or Apyrimidinic Site) LyaseHEK293 CellsHumansSynthetic BiologyDNA-(Apurinic or Apyrimidinic Site) LyaseDNA, CircularDNA, Single-Stranded

Identifiers

PMID40378217
PMCPMC12083533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.